Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–16 of 16 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neuromuscular Blockade Monitoring Clear all

Conditions: Anesthesia
Interventions: TwitchView EMG Unit, Novel QTOF Device; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Surgery, Neuromuscular Blockade
Interventions: TetraGraph; Device
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 1 Month and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Residual Paralysis, Post Anesthesia
Interventions: Protocol for Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex; Combination Product
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Muscle Weakness
Interventions: TOF-Watch SX, Notify the provider; Device · Procedure
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Residual Neuromuscular Blockade
Interventions: Tetragraph, ToFscan; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Muscle Weakness
Interventions: Protocol for rocuronium neuromuscular block; Combination Product
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Neuromuscular Blockade, Muscle Relaxation
Interventions: Train of four test; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Coronary Artery Disease, Valvular Heart Disease, Aorta Disease, Heart Failure
Interventions: Sugammadex administration; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Neuromuscular Blockade
Interventions: Train of four measurement; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Airway Management, Endotracheal Intubation
Interventions: Low-Dose Remifentanil, High-Dose Remifentanil, Succinylcholine, Rocuronium, Sugammadex; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Neuromuscular Blockade, Intraoperative Monitoring, Skin Preparation, Electromyography
Interventions: Gentle Skin Abrasion Before EMG-Based Neuromuscular Blockade Monitoring; Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Residual Neuromuscular Blockade
Interventions: TetraGraph; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Neuromuscular Blockade
Interventions: Hydraulic Monitoring Device, Standard EMG Monitoring Device; Device
Lead sponsor: Richard H Epstein; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Postoperative Residual Neuromuscular Blockade
Interventions: Tetragraph quantitative monitoring; Device
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Neuromuscular Blockade Monitoring, NMT
Interventions: Collection of NMT Technology; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Neuromuscular Blockade
Interventions: Neuromuscular Transmission Monitoring; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Loma Linda, California

Search by objective public record fields.

Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System

TetraGraph to Evaluate Onset and Recovery Times of Rocuronium

Best Management of Muscle Relaxation- Objective Monitoring

The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery

Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting

Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex

Clinical Application of "Train of Four" Testing in the Intraoperative Monitoring Setting

Sugammadex Titration in Cardiac Surgery Patients

Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring

REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring

Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade Monitoring

Thumb vs Great Toe Recovery

Validation of a Muscle Relaxation Monitor

Electromyographic Monitoring and Postoperative Recovery

NMT EasyFit Sensor and Cable

Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison